Can you interpret an ECG showing sinus rhythm with a ventricular rate of 66 bpm, PR interval 165 ms, QRS duration 127 ms, QTc 484 ms, P‑axis 37°, QRS axis –24°, T‑axis 34°, RV5 amplitude 1.39 mV and SV1 amplitude 0.48 mV, and recommend appropriate management?

ECG Interpretation: Intraventricular Conduction Delay with Borderline QTc Prolongation

This ECG demonstrates an intraventricular conduction delay (IVCD) with a QRS duration of 127 ms, borderline QTc prolongation at 484 ms, and a leftward QRS axis deviation at –24°, requiring evaluation for underlying structural heart disease and assessment of heart failure status to determine if cardiac resynchronization therapy candidacy exists.

Key ECG Abnormalities

QRS Duration and Morphology

• QRS duration of 127 ms represents an intraventricular conduction delay that does not meet criteria for complete left bundle branch block (LBBB) or right bundle branch block (RBBB), classified as nonspecific IVCD 1
• The leftward QRS axis of –24° suggests left anterior fascicular involvement or left ventricular structural abnormality 2
• This QRS duration (120-149 ms range) falls into a zone where CRT benefit is uncertain without LBBB morphology 3

QTc Prolongation

• QTc of 484 ms is borderline prolonged (normal upper limit ~460 ms in men, ~470 ms in women) and warrants medication review and electrolyte assessment 2
• The QT prolongation may be secondary to the widened QRS complex itself, as QRS prolongation mechanically extends ventricular repolarization time 4

Rate and Intervals

• Ventricular rate of 66 bpm is normal and does not suggest bradycardia requiring intervention 5, 6
• PR interval of 165 ms is normal (120-200 ms range) 7

Prognostic Implications

Mortality Risk

• Nonspecific IVCD with QRS ≥110 ms in the general population carries increased all-cause mortality (RR 2.01), cardiac mortality (RR 2.53), and arrhythmic death risk (RR 3.11) compared to normal QRS duration 4
• This risk stratification applies even in apparently healthy individuals without known cardiac disease 4
• The prognostic significance is stronger for IVCD than for isolated RBBB 4

Clinical Context Matters

• In young healthy volunteers, IVCD may be a benign finding in up to 5.9% of individuals, particularly males 2
• However, IVCD is most commonly associated with underlying cardiomyopathy (ischemic or hypertensive) rather than being an isolated finding 1

Management Algorithm

Step 1: Assess for Structural Heart Disease

Obtain echocardiography to measure:

• Left ventricular ejection fraction (LVEF) 3
• Left ventricular dimensions and wall thickness 3
• Regional wall motion abnormalities suggesting ischemic disease 1
• Valvular function 3

Step 2: Evaluate Heart Failure Status

If LVEF ≤35% and symptomatic heart failure present:

• For NYHA class II symptoms with QRS 127 ms and non-LBBB morphology: CRT is NOT recommended as QRS duration must be ≥150 ms for non-LBBB patterns 3
• For NYHA class III-IV symptoms with QRS 127 ms and non-LBBB morphology: CRT should be considered only if QRS ≥150 ms 3
• This patient's QRS of 127 ms falls below the threshold for CRT benefit in non-LBBB morphology regardless of symptom severity 3

Step 3: Address QTc Prolongation

Review and optimize:

• All medications that prolong QT interval (antiarrhythmics, antibiotics, antipsychotics, antidepressants) 2
• Serum electrolytes (potassium, magnesium, calcium) and correct deficiencies 2
• Thyroid function if not recently assessed 3

Step 4: Risk Factor Modification

Evaluate for:

• Coronary artery disease with stress testing or coronary angiography if ischemic symptoms present 1
• Hypertension control as this commonly underlies IVCD 1
• Diabetes management 5

Common Pitfalls to Avoid

Misclassification of Conduction Delay

• Do not assume this represents LBBB without confirming specific LBBB criteria (broad notched R waves in lateral leads I, aVL, V5-V6; absent Q waves in I, V5-V6) 3
• IVCD has contradictory CRT outcomes compared to true LBBB, with seemingly neutral benefit 1

Overestimating CRT Candidacy

• Guidelines are explicit that QRS duration of 130-149 ms with non-LBBB morphology receives only a Class IIb recommendation (may be considered) for CRT, not a strong recommendation 3
• At 127 ms, this patient falls below even that threshold 3

Dismissing Prognostic Significance

• Even if structural heart disease is absent initially, IVCD predicts future cardiac events and warrants longitudinal follow-up 4
• The 3-fold increased risk of arrhythmic death persists after multivariate adjustment for other risk factors 4

Ignoring Reversible Causes

• Always exclude medication effects, electrolyte abnormalities, and thyroid dysfunction before attributing IVCD to irreversible structural disease 3, 2

Follow-Up Strategy

Immediate actions:

• Echocardiography to assess LVEF and structure 3
• Comprehensive metabolic panel including electrolytes 2
• Medication review for QT-prolonging agents 2

If LVEF >35% or asymptomatic:

• Annual clinical reassessment for heart failure symptoms 3
• Repeat echocardiography if symptoms develop 3
• Maintain aggressive cardiovascular risk factor control 1

If LVEF ≤35% with symptoms:

• Optimize guideline-directed medical therapy for heart failure 3
• Reassess QRS duration and morphology after medical optimization, as some patients develop further QRS widening that may reach CRT thresholds 3
• Consider ICD evaluation based on ischemic vs non-ischemic etiology and symptom severity 3